![Cyrus Harmon](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cyrus Harmon
Oprichter bij
OLEMA PHARMACEUTICALS, INC.
Vermogen: 11 M $ op 31-05-2026
Profiel
Cyrus L.
Harmon was the founder of Neomorphics, Inc., founded in 1996, where the title held was Chief Executive Officer from 1996 to 2000.
Dr. Harmon is the founder of Olema Pharmaceuticals, Inc., founded in 2006, holding the title of Independent Director.
Dr. Harmon currently works at Vilya, Inc. as President & Chief Executive Officer since 2023.
Formerly, Dr. Harmon was General Manager at Affymetrix, Inc. from 2000 to 2002.
Education includes undergraduate and doctorate degrees from the University of California, Berkeley.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 18-06-2026 | 844.798 ( 0,97% ) | 11 M $ | 31-05-2026 |
Actieve functies van Cyrus Harmon
| Bedrijven | Functie | Begin |
|---|---|---|
| OLEMA PHARMACEUTICALS, INC. | Oprichter | 07-08-2006 |
Vilya Inc.
 Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Algemeen Directeur | 01-10-2023 |
Eerdere bekende functies van Cyrus Harmon
| Bedrijven | Functie | Einde |
|---|---|---|
| AFFYMETRIX, INC. | Corporate Officer/Principal | 01-01-2002 |
Neomorphics, Inc.
 Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Algemeen Directeur | 01-01-2000 |
Opleiding van Cyrus Harmon
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
5
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 5 |
|---|---|
Affymetrix, Inc.
 Affymetrix, Inc. Medical SpecialtiesHealth Technology Develops, manufactures and sells products and services for genetic analysis | Health Technology |
Neomorphics, Inc.
Neomorphics, Inc. Medical SpecialtiesHealth Technology Develops, analyzes, and manages genetic information to improve disease | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Olema Pharmaceuticals, Inc.
 Olema Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drugs for the treatment & prevention of estrogen receptor positive breast cancer | Health Technology |
Vilya Inc.
Vilya Inc. BiotechnologyHealth Technology Operates as a biotechnology company which develops medicines to precise disease biology | Health Technology |
